Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,270
-40 (-0.39%)
Apr 16, 2025, 3:30 PM KST
-26.38%
Market Cap 185.72B
Revenue (ttm) 268.86B
Net Income (ttm) 10.26B
Shares Out 18.01M
EPS (ttm) 557.00
PE Ratio 18.51
Forward PE n/a
Dividend 150.00 (1.45%)
Ex-Dividend Date Dec 27, 2024
Volume 20,597
Average Volume 61,387
Open 10,310
Previous Close 10,310
Day's Range 10,200 - 10,350
52-Week Range 9,540 - 15,550
Beta 0.65
RSI 47.58
Earnings Date May 14, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 637
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.